Publications by authors named "Maria Lycke"

Claim this Profile
D
Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high-grade serous ovarian carcinoma.
Amanda Olsson Widjaja, Peter Micallef, Maria Lycke, Tobias Österlund, Manuel Luna Santamaría

Int J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis.
Zhuxuan Fu, Lauren Borho, Sarah E Taylor, Linda E Kelemen, Anna DeFazio, Maria Lycke

Gynecol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancer.
Mikaela Moskov, Julia Hedlund Lindberg, Maria Lycke, Emma Ivansson, Ulf Gyllensten

Commun Med (Lond)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer - implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils.
Veronika Karlsson, Ebba Stål, Emma Stoopendahl, Anton Ivarsson, Hakon Leffler, Maria Lycke

Front Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Tissue-Resident Natural Killer and T Lymphocytes with Anti-Tumor Properties in Ascites of Ovarian Cancer Patients.
Elin Bernson, Oisín Huhn, Veronika Karlsson, Delia Hawkes, Maria Lycke

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
Martin Köbel, Eun-Young Kang, Ashley Weir, Peter F Rambau, Cheng-Han Lee, Maria Lycke

J Pathol Clin Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment.
Stefan Enroth, Emma Ivansson, Julia Hedlund Lindberg, Maria Lycke, Jessica Bergman

Commun Med (Lond)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.
Eun Young Kang, Joshua Millstein, Gordana Popovic, Nicola S Meagher, Adelyn Bolithon, Maria Lycke

Virchows Arch· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.
Ulf Gyllensten, Julia Hedlund-Lindberg, Johanna Svensson, Johanna Manninen, Torbjörn Öst, Maria Lycke

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consideration should be given to smoking, endometriosis, renal function (eGFR) and age when interpreting CA125 and HE4 in ovarian tumor diagnostics.
Maria Lycke, Benjamin Ulfenborg, Jacob Malchau Lauesgaard, Björg Kristjansdottir, Karin Sundfeldt

Clin Chem Lab Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer.
Stefan Enroth, Malin Berggrund, Maria Lycke, John Broberg, Martin Lundberg

Commun Biol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Diagnostic Accuracy of Adnexal Tumors with A Combination of Established Algorithms and Biomarkers.
Maria Lycke, Benjamin Ulfenborg, Björg Kristjansdottir, Karin Sundfeldt

J Clin Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer.
Stefan Enroth, Malin Berggrund, Maria Lycke, Martin Lundberg, Erika Assarsson

Clin Proteomics· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index.
Maria Lycke, Björg Kristjansdottir, Karin Sundfeldt

Gynecol Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.
Yuxuan Wang, Lu Li, Christopher Douville, Joshua D Cohen, Ting-Tai Yen, Maria Lycke

Sci Transl Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis